Home / Journals / ECN / Vol.31, No.1, 2020
Special Issues
  • Open AccessOpen Access

    REVIEW

    When wrinkles appear on the immune system can it be reversed?

    Hiba Sibaii1, Salwa Refat El-Zayat1, Mona Khalil2
    European Cytokine Network, Vol.31, No.1, pp. 1-17, 2020, DOI:10.1684/ecn.2020.0441
    Abstract During aging, physiological and physical frailty occur, which is accompanied by a decline in adaptive and innate immunity, termed ‘immunosenescence’ characterized by marked changes in the composition, function, and competence of the human immune system. Moreover, the capabilities of the immune system to defend the human body against infections, to detect and destruct malignant or autoreactive cells decline, resulting in an increase in the susceptibility to infection, development of cancer, as well as autoimmune disorders. The study of age-related changes in immune function is an important area of investigation. In this review, the function of More >

  • Open AccessOpen Access

    REVIEW

    Increase of circulating inflammatory molecules in preeclampsia, an update

    Gurhan Guney1, Mine Islimye Taskin1, Aytekin Tokmak2
    European Cytokine Network, Vol.31, No.1, pp. 18-31, 2020, DOI:10.1684/ecn.2020.0443
    Abstract Special hormonal and immunological changes are required for normal pregnancy continuation. To escape from rejection by the maternal immune system, pregnancy needs an optimum environment with the integration and the balance of immune factors. As an immunologically unique site that permits allogenic fetus to be tolerated by mother, the maternal–fetal interface has a vital role. Microorganisms may trigger innate immune responses at the maternal–fetal interface and this may have a significant impact on the success of pregnancy. While the presence of inflammatory markers are slightly increased in healthy pregnancies, their significant increase in preeclampsia suggests More >

  • Open AccessOpen Access

    ORIGINAL ARTICLE

    Comparing effects of low glycemic index/high-fat, high-calorie diet and high-fat, high-calorie diet on cytokine levels of patients with cystic fibrosis: A randomized controlled clinical trial

    Zahra Gorji1, Mohammadreza Modaresi2, Saeed Yekanni-Nejad3, Nima Rezaei4,5,6, Maryam Mahmoudi1,7
    European Cytokine Network, Vol.31, No.1, pp. 32-38, 2020, DOI:10.1684/ecn.2020.0442
    Abstract The importance of the host inflammatory response, as a central pathological feature of cystic fibrosis, is well recognized. Additionally, hyperglycemia can induce an immune response and consecutively may exacerbate symptoms of this disease. Hence, adherence to a low glycemic index diet, through normalizing blood glucose levels, may reduce inflammation in patients with this disease. This study aimed to compare effects of a low glycemic index/high-fat, high-calorie diet and routine high-fat, high-calorie diet on inflammatory biomarkers in patients with cystic fibrosis. In this randomized clinical trial, 44 children and adolescents with cystic fibrosis were randomly assigned… More >

  • Open AccessOpen Access

    ORIGINAL ARTICLE

    Serum levels of nesfatin-1 and irisin in obese children

    Eda Dokumacioglu1, Hatice Iskender1, Arzu Sahin2, Emine Yurdakul Erturk3, Ozgur Kaynar4
    European Cytokine Network, Vol.31, No.1, pp. 39-43, 2020, DOI:10.1684/ecn.2020.0444
    Abstract Background: Along with the developing technology in the modern age, physical activity had decreased considerably in children and adolescents alike with a concomitant and rapid increase in the prevalence of childhood obesity. The purpose of the present study is to measure the levels of serum nesfatin-1 and irisin in obese children. Methods: The present study was carried out with a total of 62 children, including 32 obese children diagnosed between June 2017 and October 2017 and 30 healthy children. Serum nesfatin-1, irisin, SOD, MDA, fasting blood glucose, total cholesterol (TC), triglyceride (TG), HDL-C, LDL-C, aspartate… More >

Per Page:

Share Link